191 related articles for article (PubMed ID: 17455969)
21. Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma.
Liang X; Zhao J; Hajivandi M; Wu R; Tao J; Amshey JW; Pope RM
J Proteome Res; 2006 Oct; 5(10):2632-41. PubMed ID: 17022634
[TBL] [Abstract][Full Text] [Related]
22. Post-translational modifications of Desulfovibrio vulgaris Hildenborough sulfate reduction pathway proteins.
Gaucher SP; Redding AM; Mukhopadhyay A; Keasling JD; Singh AK
J Proteome Res; 2008 Jun; 7(6):2320-31. PubMed ID: 18416566
[TBL] [Abstract][Full Text] [Related]
23. "Best friends" sharing the HMGA1 gene: comparison of the human and canine HMGA1 to orthologous other species.
Murua Escobar H; Soller JT; Richter A; Meyer B; Winkler S; Bullerdiek J; Nolte I
J Hered; 2005; 96(7):777-81. PubMed ID: 15958792
[TBL] [Abstract][Full Text] [Related]
24. Collective mass spectrometry approaches reveal broad and combinatorial modification of high mobility group protein A1a.
Young NL; Plazas-Mayorca MD; DiMaggio PA; Flaniken IZ; Beltran AJ; Mishra N; LeRoy G; Floudas CA; Garcia BA
J Am Soc Mass Spectrom; 2010 Jun; 21(6):960-70. PubMed ID: 20202861
[TBL] [Abstract][Full Text] [Related]
25. Tissues tell the real tale of breast cancer.
Cottingham K
J Proteome Res; 2007 Jun; 6(6):2052. PubMed ID: 17577952
[No Abstract] [Full Text] [Related]
26. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
[TBL] [Abstract][Full Text] [Related]
27. Dynamic mitochondrial localization of nuclear transcription factor HMGA1.
Dement GA; Treff NR; Magnuson NS; Franceschi V; Reeves R
Exp Cell Res; 2005 Jul; 307(2):388-401. PubMed ID: 15893306
[TBL] [Abstract][Full Text] [Related]
28. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
29. Isolation, identification and quantification of differentially expressed proteins from cancerous and normal breast tissues.
Othman MI; Majid MI; Singh M; Man CN; Lay-Harn G
Ann Clin Biochem; 2008 May; 45(Pt 3):299-306. PubMed ID: 18482919
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel in vivo phosphorylation sites in high mobility group N1 protein from the MCF-7 human breast cancer cells.
Zou Y; Jiang X; Wang Y
Biochemistry; 2004 May; 43(20):6322-9. PubMed ID: 15147216
[TBL] [Abstract][Full Text] [Related]
31. Beyond linker histones and high mobility group proteins: global profiling of perchloric acid soluble proteins.
Zougman A; Wiśniewski JR
J Proteome Res; 2006 Apr; 5(4):925-34. PubMed ID: 16602700
[TBL] [Abstract][Full Text] [Related]
32. High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A.
Adair JE; Maloney SC; Dement GA; Wertzler KJ; Smerdon MJ; Reeves R
Cancer Res; 2007 Jul; 67(13):6044-52. PubMed ID: 17616660
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.
Cleynen I; Huysmans C; Sasazuki T; Shirasawa S; Van de Ven W; Peeters K
Cancer Res; 2007 May; 67(10):4620-9. PubMed ID: 17510387
[TBL] [Abstract][Full Text] [Related]
34. Identification of new high mobility group A1 associated proteins.
Pierantoni GM; Esposito F; Giraud S; Bienvenut WV; Diaz JJ; Fusco A
Proteomics; 2007 Oct; 7(20):3735-42. PubMed ID: 17880001
[TBL] [Abstract][Full Text] [Related]
35. Dual role for SUMO E2 conjugase Ubc9 in modulating the transforming and growth-promoting properties of the HMGA1b architectural transcription factor.
Li Y; Lu J; Prochownik EV
J Biol Chem; 2007 May; 282(18):13363-71. PubMed ID: 17350957
[TBL] [Abstract][Full Text] [Related]
36. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
37. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
38. Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX.
Li S; Xu H; Ding H; Huang Y; Cao X; Yang G; Li J; Xie Z; Meng Y; Li X; Zhao Q; Shen B; Shao N
J Pathol; 2009 Jul; 218(3):327-36. PubMed ID: 19291713
[TBL] [Abstract][Full Text] [Related]
39. Systematic screening of protein modifications in four kinases using affinity enrichment and mass spectrometry analysis with unrestrictive sequence alignment.
Zhang K; Zhu Y; He X; Zhang Y
Anal Chim Acta; 2011 Apr; 691(1-2):62-7. PubMed ID: 21458632
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K
Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
